ADAM, Zdeněk, Karol BOLČÁK, J. STANÍČEK, Tomáš BÜCHLER, Luděk POUR, Marta KREJČÍ, J. PRÁŠEK, J. NEUBAUER, Jiří VORLÍČEK and Roman HÁJEK. Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance. Neoplasma. Bratislava: Slovak Academic Press, Ltd., 2007, vol. 54, No 6, p. 536-540. ISSN 0028-2685.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance
Name in Czech Fluorodeoxyglukosa pozitronová emisní tomografie u mnohočetného myelomu, ojedinělého plasmocytomu a monoklonální gamapatie nejasného významu
Authors ADAM, Zdeněk (203 Czech Republic, guarantor), Karol BOLČÁK (703 Slovakia), J. STANÍČEK (203 Czech Republic), Tomáš BÜCHLER (703 Slovakia), Luděk POUR (203 Czech Republic), Marta KREJČÍ (203 Czech Republic), J. PRÁŠEK (203 Czech Republic), J. NEUBAUER (203 Czech Republic), Jiří VORLÍČEK (203 Czech Republic) and Roman HÁJEK (203 Czech Republic).
Edition Neoplasma, Bratislava, Slovak Academic Press, Ltd. 2007, 0028-2685.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.208
RIV identification code RIV/00216224:14110/07:00035880
Organization unit Faculty of Medicine
UT WoS 000251196600012
Keywords (in Czech) mnohočetný myelom; pozitronová emisní tomografie
Keywords in English multiple myeloma; monoclonal gammapathy of unknown significance; plasmocytoma; PDG-PET
Tags multiple myeloma, PDG-PET, plasmocytoma
Tags International impact, Reviewed
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 22/6/2009 16:29.
Abstract
The aim of our study was to evaluate the role of fluorine-18 fluorodeoxyglucose positron emission tomography (FDGPET) in 49 patients with plasma cell malignancies. FDG-PET results were verified by conventional imaging methods, including plain radiographs, magnetic resonance imaging (MRI) and computer tomography (CT). We conclude that FDG PET might contribute to initial staging of MM patients with negative bone radiographs and is useful for the follow-up of patients in remission especially in non-secretory MM and in patients with large plasmocytoma (>5 cm) after radiochemotherapy.
Abstract (in Czech)
Cílem této publikace je vyhodnotit roli fluorodeoxyglukóza pozitronové emisní tomografie u 49 sledovaných pacientů s malignitami plazmatických buněk.
PrintDisplayed: 10/6/2024 21:41